Detection of human influenza A (H1N1) and B strains with reduced sensitivity to neuraminidase inhibitors

被引:72
作者
Escuret, Vanessa [1 ]
Frobert, Emilie [1 ]
Bouscambert-Duchamp, Maude [1 ]
Sabatier, Murielle [1 ]
Grog, Isidore [3 ]
Valette, Martine [2 ]
Lina, Bruno [1 ,2 ]
Morfin, Florence [1 ]
Ferraris, Olivier [1 ]
机构
[1] Univ Lyon 1, CNRS, FRE 3011, F-69372 Lyon 08, France
[2] Ctr Biol Est, Hospices Civils Lyon, CNR Virus Influenza France Sud, F-69677 Bron, France
[3] OpenRome, GROG, F-75018 Paris, France
关键词
influenza; neuraminidase inhibitors; resistance; systematic monitoring;
D O I
10.1016/j.jcv.2007.10.019
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Background: Neuraminidase inhibitors (NAIs) have been used since 2005 in France. Objective: Influenza viruses isolated in hospital and community cases in winter 2005-2006 were evaluated for their sensitivity to NAIs. Study design: Isolates were tested in duplicate with a fluorescence-based neuraminidase assay. The IC50 for oseltamivir or zanamivir was calculated for each strain. Mean IC50 (+/-S.D.) are expressed in nM. Viruses with IC50 superior or very superior to the upper limit (mean IC50 + 2.5 S.D.) were considered as outliers or resistant viruses, respectively. HA and NA genes for outliers, resistant strains and for a few sensitive strains were sequenced. Results: Out of 225 B isolates, one was found resistant to both oseltamivir and zanamivir with a D197Y mutation in NA and eight isolates were outliers for oseltamivir and/or zanamivir. Out of 151 A (H1N1) isolates, one was found resistant to oseltamivir but sensitive to zanamivir with a H275Y mutation in NA, two isolates were resistant to zanamivir and three isolates were outliers for oseltamivir and/or zanamivir. New mutations were detected in outliers compared to sensitive viruses. Conclusion: Resistant influenza strains to NAIs are circulating at a stable and low level of 1% since the introduction of NAIs in clinical practice. (C) 2007 Elsevier B.V. All rights reserved.
引用
收藏
页码:25 / 28
页数:4
相关论文
共 18 条
  • [1] Brief report - Oseltamivir resistance during treatment of influenza A (H5N1) infection
    de Jong, MD
    Thanh, TT
    Khanh, TH
    Hien, VM
    Smith, GJD
    Chau, NV
    Cam, BV
    Qui, PT
    Ha, DQ
    Guan, Y
    Peiris, JSM
    Hien, TT
    Farrar, J
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (25) : 2667 - 2672
  • [2] Sensitivity performed of influenza viruses to zanamivir and oseltamivir: A study on viruses circulating in France prior to the introduction of neuraminidase inhibitors in clinical practice
    Ferraris, O
    Kessler, N
    Lina, B
    [J]. ANTIVIRAL RESEARCH, 2005, 68 (01) : 43 - 48
  • [3] Molecular mechanisms of influenza virus resistance to neuraminidase inhibitors
    Gubareva, LV
    [J]. VIRUS RESEARCH, 2004, 103 (1-2) : 199 - 203
  • [4] Selection of influenza virus mutants in experimentally infected volunteers treated with oseltamivir
    Gubareva, LV
    Kaiser, L
    Matrosovich, MN
    Soo-Hoo, Y
    Hayden, FG
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2001, 183 (04) : 523 - 531
  • [5] Emergence of influenza B viruses with reduced sensitivity to neuraminidase inhibitors
    Hatakeyama, Shuji
    Sugaya, Norio
    Ito, Mutsumi
    Yamazaki, Masahiko
    Ichikawa, Masataka
    Kimura, Kazuhiro
    Kiso, Maki
    Shimizu, Hideaki
    Kawakami, Chiharu
    Koike, Kazuhiko
    Mitamura, Keiko
    Kawaoka, Yoshihiro
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2007, 297 (13): : 1435 - 1442
  • [6] Influenza viruses resistant to the antiviral drug oseltamivir: Transmission studies in ferrets
    Herlocher, ML
    Truscon, R
    Elias, S
    Yen, HL
    Roberts, NA
    Ohmit, SE
    Monto, AS
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2004, 190 (09) : 1627 - 1630
  • [7] Rescue of influenza B virus from eight plasmids
    Hoffmann, E
    Mahmood, K
    Yang, CF
    Webster, RG
    Greenberg, HB
    Kemble, G
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (17) : 11411 - 11416
  • [8] Universal primer set for the full-length amplification of all influenza A viruses
    Hoffmann, E
    Stech, J
    Guan, Y
    Webster, RG
    Perez, DR
    [J]. ARCHIVES OF VIROLOGY, 2001, 146 (12) : 2275 - 2289
  • [9] Neuraminidase inhibitor-resistant and -sensitive influenza B viruses isolated from an untreated human patient
    Hurt, AC
    Iannello, P
    Jachno, K
    Komadina, N
    Hampson, AW
    Barr, IG
    McKimm-Breschkin, JL
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2006, 50 (05) : 1872 - 1874
  • [10] Identification of a human influenza type B strain with reduced sensitivity to neuraminidase inhibitor drugs
    Hurt, AC
    McKimm-Breschkin, JL
    McDonald, M
    Barr, IG
    Komadina, N
    Hampson, AW
    [J]. VIRUS RESEARCH, 2004, 103 (1-2) : 205 - 211